Related Experiment Video
Updated: Oct 4, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
COVID-19-Related Multisystem Inflammatory Syndrome in Children Presenting With New-Onset Type 1 Diabetes in Severe
Hanan H Aly1, Eman M Fouda2, Alyaa A Kotby3
1Division of Pediatric Diabetology, Department of Pediatrics.
Insights
Multisystem inflammatory syndrome in children (MIS-C) can present with new-onset type 1 diabetes mellitus (T1DM) in severe diabetic ketoacidosis (DKA). Early recognition of this critical overlap is vital for effective patient management.
Area of Science:
- Pediatrics
- Endocrinology
- Infectious Diseases
Background:
- Coronavirus disease 2019 (COVID-19) can trigger multisystem inflammatory syndrome in children (MIS-C).
- MIS-C has been associated with various clinical presentations, including cardiac involvement and shock.
Purpose of the Study:
- To describe cases of pediatric patients with COVID-19-related MIS-C presenting with new-onset type 1 diabetes mellitus (T1DM).
- To characterize the clinical features and management of children with MIS-C and severe diabetic ketoacidosis (DKA).
Main Methods:
- Prospective observational study.
- Inclusion criteria: Children meeting Centers for Disease Control and Prevention and World Health Organization criteria for MIS-C and presenting with new-onset T1DM in DKA.
Main Results:
- Six critically ill children were identified.
- All patients presented with severe DKA, non-fluid responsive shock, and cardiac involvement.
- One patient exhibited a Kawasaki shock-like presentation.
- Treatment included aggressive fluid management, vasoactive/inotropic support, methylprednisolone, and intravenous immunoglobulins, with immunoglobulins administered after DKA resolution.
Conclusions:
- Coexistence of MIS-C with new-onset T1DM in DKA requires prompt recognition.
- Timely and appropriate management is crucial for improving outcomes in these critically ill children.
Objective:
To report and describe cases of children presenting with coronavirus disease 2019 (COVID-19)-related multisystem inflammatory syndrome in children (MIS-C) with new-onset type 1 diabetes mellitus (T1DM) in severe diabetic ketoacidosis (DKA).
Research Design And Methods:
This prospective observational study was conducted to characterize children with COVID-19-related MIS-C and new-onset T1DM who were in DKA. MIS-C was diagnosed if Centers for Disease Control and Prevention and World Health Organization criteria were fulfilled.
Results:
Six cases were identified. The patients were critically ill and in nonfluid responsive shock (combined hypovolemic and cardiogenic or distributive shock). All had cardiac involvement. One patient had a Kawasaki shock-like presentation. All needed aggressive treatment with careful monitoring of fluid balance (because of associated cardiac dysfunction), early institution of vasoactive/inotropic supports, and use of methylprednisolone and intravenous immunoglobulins. The latter are better administered after DKA resolution to avoid undue volume overload and fluid shifts while the patients are in DKA.
Conclusions:
Awareness of MIS-C coexistence with DKA at T1DM onset is crucial for rapid proper management.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Acute Pancreatitis II: Clinical Manifestations and Management

